Pierre Chelle

Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation

Mohamed Aborig, Paul Malik, Shruti Nambiar et al. · Pharmaceutics · 2019 · 52 citations · Full text

Nanoparticles, Engineering, Metal Nanoparticles +20

Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?

Manuel Carção, Pierre Chelle, Emily Clarke et al. · Journal of Thrombosis and Haemostasis · 2019 · 47 citations · Full text

Pediatric Hematology, Pharmacology, Hematology +4

Integrated Electrochemical Aptamer Biosensing and Colorimetric pH Monitoring via Hydrogel Microneedle Assays for Assessing Antibiotic Treatment

Fatemeh Keyvani, Peyman GhavamiNejad, Mahmoud Ayman Saleh et al. · Advanced Science · 2024 · 38 citations · Full text

Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization

Alanna McEneny‐King, Pierre Chelle, Gary Foster et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2019 · 35 citations

Pharmacokinetic Modeling, Dose Individualization, Hematology +3

Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup

Pierre Chelle, Cindy H. T. Yeung, Stacy E. Croteau et al. · Clinical Pharmacokinetics · 2019 · 26 citations

Pharmacokinetic Modeling, Pharmacotherapy, Rurioctacog Alfa Pegol +5